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ies in the tropics are necessary to deﬁne the impact and
seasonality of inﬂuenza in these regions. These data could
help identify the optimal timing of vaccination programs and
other measures for the prevention and control of seasonal
and pandemic inﬂuenza in the tropics, including protection
for travelers and control of emerging strains.
doi:10.1016/j.ijid.2010.02.1680
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Novel inﬂuenza A H1N1 (NIA) infection in Argentinean
Children — Experience at Hospital de Nin˜os ‘‘Ricardo
Gutiérrez’’
E.L. Lopez ∗, A. Fallo, M.M. Contrini, A. Mistchenko, C.
Molise, S. Neyro, N. Gonzalez, D. Lazzarini, G. Manonelles,
J. Grichener, M. Dastugue, A. Teper, N. Study Group
Hospital de Nin˜os ‘‘Ricardo Gutiérrez’’, Buenos Aires,
Argentina
Background: NIA pandemia (P) began in Argentina dur-
ing respiratory virus season. Hospital Gutiérrez (HG) set
up special outﬁtted examination room trailler; 5000 sus-
pected cases were attended in 2 mo. Health care for P
included 2 different stages: May24-June12, 695 outpatients
mainly school-age were attended [Containment Phase(CP)].
After 17 ds with a widespread disease: June12-July11, 110
children were admitted to HG due to respiratory failure [Mit-
igation Phase(MP)]
Objective: to characterize clinical, lab and treatment of
conﬁrmed NIA patients (pts)
Methods: IFA was used to rule out other RV; conﬁrmation
by RT-PCR
Results: CP: 220/695(61.3%) cases were conﬁrmed;
191students, 15 close contacts (CC), 8 international trav-
elers, 3 teachers; 2 health-workers. The 191 conﬁrmed
student cases are reported: mean age: 9± 3(4-17) yr; 16(8%)
had comorbidity(C). Most frequent symptoms: fever(F)
178(93%) and cough(Co)160(64%). Oseltamivir(Os) was pre-
scribed to 150(78.5%); none of them was hospitalized.
Duration of F and Co was lower in treated than untreated 2,1
vs 3.6 ds, and 4.2 vs 7 ds respectively(p < 0.001). Secondary
cases occurred in 41/297(15%) of CC, 12/31 in CC without
Os prophylaxis (OsP) and 29/266 in CC with OsP(p = 0.0002).
Mild adverse events(AE) by Os were reported in 12% of
treated pts and in 6.3% of CC
MP: 110 NIA cases represented 6.9% of admis-
sions during this period (double of usual seasonal ﬂu
cases/yr). Mean age 43.4(±54.4) mo; 61(55.5%) were
younger than 24 mo. Main symptoms on admission: F
106(97.4%) and bronchiolitis 70(63.6%). C was present in
84/110(76.4%), it was more frequent in children > 24 mo:
38/61(62.3%) than younger 46/49(93.9%)(p < 0.0003). Fif-
teen(13,6%) required ICU. Complications: 69/110(62.7%)
pts; pneumonia 52/110(47.3%); pneumonitis 31/110(28.2%)
[16/52(30.8%) had both X-Ray patterns]; encephalitis 1/110
(0.9%). Os treatment: 108(98.2%); AE 1/108(0.9%): unspe-
ciﬁc exanthema. Mortality 6/110(5.5%); all of them had C;
median age:87mo
Conclusion: NIA was mild in school-age pts
m
A
I
l
p
o
tts e87
Admissions by NIA were twice higher than seasonal ﬂu
nnually
Os was well tolerated by children
Os statistically reduced duration of F and Co
Os was effective to prevent secondary cases in CC
Mortality was low in hospitalized children, associated to
omorbidity
oi:10.1016/j.ijid.2010.02.1681
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ssessing the risk of Inﬂuenza virus strains isolated from
irds and mammals to humans
. Vdovichenko1,∗, A. Sergeev1, O.K. Demina1, A.
abanov1, A.S. Kudriavcev2, A.V. Pal’cev2, U.E. Narov2,
.N. Shishkina1, I.G. Drozdov1
FRSI State research center of virology and biotechnology
‘Vector’’, Novosibirsk, Russian Federation
Novosibirsk Regional Oncological Clinic, Novosibirsk, Rus-
ian Federation
Background: Inﬂuenza A virus is the subject of research
f many scientists in the world. So now the attention of sci-
ntists focused on the problem of inﬂuenza, ﬁrst because
f the increased outbreaks of avian inﬂuenza in the world
nd the incidence of transmission of the disease to people
ho were in contact with sick birds. Secondly the threat
oday is the inﬂuenza virus of H1N1 subtype, which caused
any diseases among people around the world. In this con-
ection assessment of risk to human inﬂuenza virus strains
f various origins is essential for timely implementation of
ffective anti-epidemic measures in order to prevent the
evelopment of an epidemic or pandemic inﬂuenza. We have
valuated parameters of infectivity of inﬂuenza virus strains
H5N1, H1N1 and H3N2 subtypes) for primary cell culture
btained from human lung tissues.
Methods: Three inﬂuenza A/Chicken/Suzdalka/2/05
H5N1), A/Novosibirsk/1/09 (H1N1) and A/Aichi/2/68
H3N2) virus strains from the collection of research insti-
ute of FRSI SRC VB ‘‘Vector’’ and primary cell cultures
btained from pieces of human lung tissue kindly provided by
olleagues from the Regional Oncology Center of the Novosi-
irsk, Russia have been used.
Results: A comparison of the values 50% cell infect-
ng dose (CID50) of strains found that the susceptibility
f human lung cells to inﬂuenza A/Chicken/Suzdalka/2/05
irus strain in the 10 and 100 times more than values both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains respec-
ively. However inﬂuenza A/Chicken/Suzdalka/2/05 strain
ad a 10 times lower progeny yield during 20 hours of repli-
ation in human lung cells compared with other strains.
Conclusion: Thus, our studies revealed inﬂuenza
/Chicken/Suzdalka/2/05 virus strain is able to
ore easily infect cells of the respiratory tract of
an, but has a lower replicate activity than both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains.
nﬂuenza A/Chicken/Suzdalka/2/05 virus strain was iso-
ated during an outbreak of avian ﬂu among wild birds and
oultry in the Novosibirsk region. During this period of the
utbreak have not been established cases of avian inﬂuenza
ransmission from birds to local residents. Perhaps this is due
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o the low replicate activity of A/Chicken/Suzdalka/2/05
irus strain, which we evaluated in our studies.
oi:10.1016/j.ijid.2010.02.1682
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n vitro inactivation of avian inﬂuenza virus by Capryilic
cids and its derivatives
.I. Hariastuti ∗, S. Babapoor, Y. Huang, M.I. Khan
University of Connecticut, Storrs, CT, USA
Background: Avian inﬂuenza is an important disease as
t causes signiﬁcant economic losses to the poultry indus-
ry. Further, transmission of the virus to humans enhanced
he major public health signiﬁcance. Since the virus is
ighly contagious, strict hygienic measures employed at the
oultry farms can greatly help prevent the virus from spread-
ng. Contaminated food, water, and poultry manure are
ost important vehicles of the virus to infect animals and
umans. Effective and safe antimicrobials that kill the virus
n the aforementioned vehicles could greatly reduce spread
f the virus. Caprylic acid is a natural fatty acid and its other
hemical forms, namely sodium caprylate and monocaprylin
re highly effective in killing a variety of disease causing
acteria and viruses.
Methods: Low pathogenic avian inﬂuenza viruses H5N1
nd H5N2 were subjected to caprylic acid, sodium caprylate
nd monocaprylin. Concentrations of viruses were deter-
ined using TCID50 in the cell culture. Plaque assays were
ptimized and 100 PFU viruses were used to infect chicken
mbryo kidney cells. Serial dilutions of fatty acid compounds
ere made from 0.005% to 0.5% for each virus to observe
heir virucidal effects in plaque assays. The effect of the
aprylic acid to virus particles was observed using the trans-
ission electron microscope.
Results: Caprylic acid and its derivatives were able
o inhibit the plaque forming in chicken embryo kidney
ells. The minimum inhibitory concentrations were 0.5% for
aprylic acid, 0.1% for sodium caprylate and 0.05% for mono-
aprylin. Using transmission electron microscope, negative
taining of avian inﬂuenza virus particles treated with 0.5%
aprylic acid indicated disruption of cell membrane and
nvelope of the viral particle.
Conclusion: Low concentration of caprylic acid and its
erivatives in-vitro can reduce or inhibit avian inﬂuenza
irus. Therefore, caprylic acid and its derivates are poten-
ial to be effective and safe antimicrobials that can be used
n poultry feed in order to reduce transmission to humans.
oi:10.1016/j.ijid.2010.02.1683
t
t
c
a
v
a
s
a
dternational Congress on Infectious Diseases (ICID) Abstracts
8.014
evelopment of new effective antiinﬂuenza drugs based
n extracts of basidiomycetes
. Kabanov ∗, A.O. Sementsova, M.O. Skarnovich, T.V.
eplyakova, L.N. Shishkina, A.N. Sergeev
FSRI State research center of virology and biotechnology
‘Vector’’, Novosibirsk, Russian Federation
Background: Due to the high incidence of respiratory
iseases in humans caused by inﬂuenza viruses of dif-
erent subtypes are now particularly relevant search for
ew curative and preventive drugs against inﬂuenza. Many
pecies and strains of basidiomycetes are producers of
atural compounds exhibiting anti-tumor and antiblastic
ctivity, cytostatic effect and antiviral effect. Speciﬁc
omponents of different bio-genetic origin, with antibac-
erial, antifungal, nematodocidal, cytotoxic, antiviral, and
ther pharmacological properties of the basidiomycetes
ere identiﬁed in different investigations. Study of antivi-
al activity of extracts isolated from basidiomycetes against
nﬂuenza virus, including highly pathogenic avian inﬂuenza
nd creation on their basis of new non-toxic antiviral drugs is
ssential for health. In the present investigation was carried
ut screening and studying of antiviral activity of basid-
omycete extracts in experiments on MDCK cells for avian
nﬂuenza A/H5N1 virus.
Methods: In present study more than 70 water extracts
f fungi of the genera Rleurotus, Ganoderma, Laeti-
orus, Inonotus, Lentipus obtained from the laboratory
ollection of fungal cultures and the simplest of SRC VB
‘Vector’’ were used. The antiviral effect of extracts of
ungi was assessed by highly pathogenic avian inﬂuenza
/chicken/Kurgan/05/2005 (H5N1) virus strain and MDCK
ells.
Results: The results showed that many of the studied
xtracts of basidiomycetes have not toxicity to MDCK cells
nd thus exhibit a high antiviral efﬁcacy. This fact was noted
n the evaluation of A/chicken/Kurgan/05/2005 infectivity
n model of MDCK cells, when cultured with inﬂuenza virus
train in the presence and absence of tested drugs. Some
queous extracts of fungi Ganoderma, Laetiporus, Inono-
us and Lentipus has been shown in vitro to have high up
o 1000- 10000 times neutralization activity for inﬂuenza
/chicken/Kurgan/05/2005 virus strain.
Conclusion: One possible reason for the effectiveness of
he audited extracts isolated from the basidiomycetes is
he presence of polysaccharides. The spectrum of polysac-
harides, ﬂavonoids, melanins, mycelium and fruit of body
nd other biologically active substances of basidiomycetes is
ery wide. The results of the studies of fungi extracts suggest
bout the great prospects associated with the study of sub-
tances from basidiomycetes to create new highly effective
ntiviral therapeutic preparations on their basis.
oi:10.1016/j.ijid.2010.02.1684
